“…NT-3 has also been administered in a range of studies in association with scaffolds of various types, composed of collagen Houweling, van Asseldonk, et al, 1998;Li et al, 2016;Yao et al, 2013), fibrin (Guo et al, 2007;Taylor, Jones, et al, 2006;Wilems et al, 2015), matrigel (Bamber et al, 2001), hyaluronic acid/PLGA (Wen et al, 2015), chitosan , or hydrogels (Piantino et al, 2006;Tsai et al, 2006). Improved outcomes using a combination of NT-3 gradients, peripheral conditioning lesions, and stromal cell grafts up to 15 months after SCI have also been reported (Kadoya et al, 2009).…”